Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | NA0739 | IM / LA |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Pain/swelling at injection site L arm with persistent soft tissue prominence >1 mo pain with certain movements (internal rotation)
None
AVM (arteriovenous malformation) of colon; CLL (chronic lymphocytic leukemia) (HHS/CMS-HCC); Colon polyps; Diverticulosis of large intestine without hemorrhage; Hyperlipidemia; Hypothyroidism; Insomnia, persistent; Internal hemorrhoids; At low risk for fall; Blood in urine; BMI 22.0-22.9, adult; Bruit of right carotid artery; Contact with and (suspected) exposure to covid-19; Encounter for screening for depression; Encounter for screening for malignant neoplasm of prostate; Medicare annual wellness visit, subsequent; Hiccups; Leukocytosis; Sensation of fullness in right ear; Hypercholesterolemia; First degree hemorrhoids; Chronic lymphocytic leukemia of B-cell type not having achieved remission (HHS/CMS-HCC); Annual physical exam
Albuterol HFA 90mcg/act; atorvastatin 20 MG; cholecalciferol 50 MCG (2000 UT); levothyroxine 100 MCG; mirtazapine 15 MG; tamsulosin 0.4 MG
NKDA
ultrasound (ordered)